Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06942117

Investigating the Effect of Caffeine Consumption on Speech Understanding in Noise in Young Adults

Caffeine is a widely consumed substance worldwide and is often used to increase alertness and improve cognitive functions. Caffeine stimulates brain activity by binding to adenosine receptors, which increases alertness instead of sleepiness. Studies on the effects of caffeine on cognitive functions have shown that it improves basic cognitive functions such as attention, reaction time, and alertness, while a less pronounced effect is seen on sensory functions such as vision and hearing. However, no study has been found investigating the effect of caffeine consumption on understanding speech in noise. Understanding speech in noise is a skill that includes not only auditory functions but also cognitive functions. This skill is affected by cognitive elements such as selective attention and executive functions. In this context, it is thought that this study, which aims to examine the relationship between caffeine and understanding speech in noise, will contribute to the literature. 60 participants between the ages of 18-30 will be included in this study. Participants will consist of individuals without hearing loss (SSO<25 dB nHL), no history of neurological or psychological disorders, non-smokers, and those who do not use ototoxic drugs. Participants will be randomly divided into a placebo group that consumes decaffeinated coffee and a study group that consumes coffee containing 300 mg caffeine. The Turkish Matrix Test will be administered 30 minutes after coffee consumption. In addition, participants will be asked to keep a caffeine diary for one week to determine their daily caffeine consumption and will be asked to fill out the Caffeine Use Disorder Scale. Thus, they will be divided into low and high caffeine consumption groups and their speech understanding skills in noise will be compared.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

İstanbul Aydin University

Istanbul, Turkey (Türkiye)

Location status: Recruiting

Location contact

Merve MERAL ÇETİNKAYA

CONTACT

[email protected]

+905382835187

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • For both groups, it was planned to include individuals who had no hearing loss (SSO<25 dB nHL), no history of neurological or psychological disorders, were non-smokers, and did not use ototoxic drugs.

Exclusion criteria

Treatment and study plan

Experimental

Other

Approximately 280 grams of caffeine containing coffee will be given

Placebo

Other

Decaffeinated coffee will be given.

Primary outcomes

  1. Turkish Matrix Test

    Time frame: Before and 30 minutes after drinking coffee

    The test will be administered using the Oldenburg Measurement Application (OMA) software. Using the adaptive procedure, the signal-to-noise ratio (SNR-50) at which the individual repeats the words correctly at 50% will be found. Accordingly, the noise will be given continuously, kept constant at 65 dB SPL throughout the test. The test will start at 0 dB signal-to-noise ratio (SNR). There are sentences consisting of 5 words in the test. If the participant repeats at least three of the five words presented to him/her correctly, the SNR will decrease and if he/she does not repeat at least three words correctly, the SNR will increase. A total of 20 sentences will be presented to the participants.

Secondary outcomes

  1. Caffeine Use Disorder Scale

    Time frame: Before consuming caffeine.

    This scale, developed by Ágoston et al. (2018), consists of 10 items based on the nine criteria recommended for caffeine use disorder specified in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The scale measures the severity of caffeine use symptoms in the last twelve months. As the scale score increases, caffeine use disorder symptoms also increase. Kaya et al. (2021) conducted the Turkish validity and reliability study of the scale. The total score that can be obtained from this scale varies between 10 and 40 and there is no reverse item. The questions are graded as "1=never, 2=sometimes, 3=often, 4=very often" and are interpreted as caffeine use disorder increases as the scale score increases. In the reliability analysis, Cronbach alpha internal consistency coefficient was found to be 0.86, and the intraclass correlation coefficient was found to be 0.83.

Study contacts

Contact information is provided by the study sponsor or research team.

Merve MERAL ÇETİNKAYA

CONTACT

[email protected]

+905382835187

Sponsors and collaborators

Lead sponsor

Istanbul Aydın University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Apr 24, 2025
Registry last updated
Apr 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.